(11-L-THREONINE, 29-L-ARGININE)LACTOFERRIN(HUMAN) PRODUCED BY ASPERGILLUS NIGER VAR. AWAMORI
Recurrent Squamous Cell Carcinoma of the Oropharynx
Stanford Universityprotein_peptidePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Recurrent Squamous Cell Carcinoma of the Oropharynx cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cetuximab National Cancer Institute (NCI) | Phase 1/2 | B |
Irinotecan AIDS Malignancy Consortium | Phase 1/2 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
CIS-DIAMMINEDICHLOROPLATINUM II ImmunityBio, Inc. | Phase 2 | CCC |
had5-hpv vaccine ImmunityBio, Inc. | Phase 2 | CCC |
View all 31 →
Same molecule, other indications
(11-L-THREONINE, 29-L-ARGININE)LACTOFERRIN(HUMAN) PRODUCED BY ASPERGILLUS NIGER VAR. AWAMORI is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →